SF 482 (see companion bill HF 544) – Minnesota

Status: In Process
Year Introduced: 2023
Link: https://www.revisor.mn.gov/bills/bill.php?f=SF482&y=2023&ssn=0&b=senate

prohibits pharmacy benefit managers (“PBMs”) and health carriers from requiring that a clinician-administered drug or the administration of such a drug be covered as a pharmacy benefit. This bill further establishes a requirement that enrollees be permitted to obtain a clinicianadministered drug from a provider authorized to administer the drug, or a pharmacy. S.F. 482 creates several additional prohibitions for PBMs and health carriers, including from requiring clinicianadministered drugs to be dispensed by a pharmacy selected by the PBM or health carrier (or limiting coverage in such situations) as well as from reimbursing a provider or pharmacy for clinicianadministered drugs and their administration at a lower amount than that which would be applied to an affiliated pharmacy or pharmacy selected by the PBM or health carrier

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found